Table 4. Significant predictors of response in multivariate analyses of patients with RBC transfusion‐dependent lower‐risk myelodysplastic syndromes.

^a≥6 versus <6 cycles describes the planned number of azacitidine treatment cycles in each study, not the actual number of treatment cycles received.

Abbreviations: CI, confidence interval; ESA, erythropoietin stimulating agent; RBC, red blood cell; TD, transfusion‐dependent; TI, transfusion‐independent.